Peter F. Searle
Cancer Research UK Institute for Cancer Studies
University of Birmingham
Edgbaston
Birmingham
Name/email consistency: high
- Nitroreductase: a prodrug-activating enzyme for cancer gene therapy. Searle, P.F., Chen, M.J., Hu, L., Race, P.R., Lovering, A.L., Grove, J.I., Guise, C., Jaberipour, M., James, N.D., Mautner, V., Young, L.S., Kerr, D.J., Mountain, A., White, S.A., Hyde, E.I. Clin. Exp. Pharmacol. Physiol. (2004)
- Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene. Searle, P.F., Weedon, S.J., McNeish, I.A., Gilligan, M.G., Ford, M.J., Friedlos, F., Springer, C.J., Young, L.S., Kerr, D.J. Adv. Exp. Med. Biol. (1998)